Polymorphism of Interleukin 6 -174 G/C in Behcet Disease: Case Series and Review of Literature

  • Amira Hamzaoui Mail Department of Internal Medicine, Fattouma Bourguiba Hospital, Monastir, Tunisia.
  • Rim Klii Department of Internal Medicine, Fattouma Bourguiba Hospital, Monastir, Tunisia.
  • Olfa Harzallah Department of Internal Medicine, Fattouma Bourguiba Hospital, Monastir, Tunisia.
  • Touhami Mahjoub Department of Internal Medicine, Fattouma Bourguiba Hospital, Monastir, Tunisia.
  • Silvia Mahjoub Department of Genetic, University of Pharmacology, Monastir, Tunisia.
Keywords:
Behcet disease, IL 6, Polymorphism IL6

Abstract

To assess the association between polymorphisms of the IL-6 -174 G/C and Behçet's disease (BD) in Tunisian patients. DNA was extracted from blood samples taken from 43 Tunisian patients and 43 healthy controls. The polymorphisms were analyzed by PCR with the PCR-RFLP. No significant association was found between patients and controls concerning polymorphism of IL6 -174 G/C between the (allelic frequency: C (17.44 vs 8, 13%; P=0.17) et G (82,55 vs 91,86%; P= 0.21). Neither age of onset of BD nor sex appears to be influenced by allelic variation of SNP-174 G / C of IL6. Disease duration of BD was longer in patients having the form 174 G-allele. SNP -174G/C was more frequent in patients without significant association (32.5 vs 16,26% ; P=0.07). SNP -174 G/C was not associated with the HLA B51. Neither age of onset of BD nor sex appears to be influenced by SNP-174 G / C of IL6. Disease duration of BD was longer in the absence of the SNP-174 G/C IL6, with no significant difference (79.2 + / -45.095 vs.70.28 + / - 47.034 months, P=0.59). The polymorphism of IL6 -174 G/C does not modulate clinical expression of BD. The single nucleotide polymorphisms of the IL-6 do not appear to be associated with BD reconstruction.

References

Davatchi F. Shahram F, Chams-Davatchi C, et al. Behcet's disease: from East to West. Clin Rheumatol 2010;29(8):823-33.

Hamzaoui K, Hamzaoui A, Guemira F, et al. Cytokine profile in Behcet’s disease patients. Relationship with disease activity. Scand J Rheumatol 2002;31(4):205-10.

Mendoza-Pinto C, García-Carrasco M, Jiménez-Hernández M, et al. Etiopathogenesis of Behçet's disease. Autoimmun Rev 2010;9(4):241-5.

Ben Ahmed M, Houman H, Miled M, et al. Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behçet’s disease. Arthritis Rheum 2004;50(7):2291-5.

Dilek K, Özcimen A, Saricaoglu H, et al. Cytokine gene polymorphisms in Behçet's disease and their association with clinical and laboratory findings. Clin Exp Rheumatol 2009;27(2 Supl 53): S73-8.

Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998;102(7):1369-76.

Pascual M, Nieto A, Mataran L, et al. IL-6 promoter polymorphisms in rheumatoid arthritis. Genes Immun 2000;1(5):338-40.

Suzuki Y, Saito H, Kasanuki J, et al. Significant increase of interleukin 6 productions in blood mononuclear leukocytes obtained from patients with active inflammatory bowel disease. Life Sci 1990;47(24):2193-7.

Linker-Israeli M, Deans RJ, Wallage DJ, et al. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. J Immunol 1991;147(1):117-23.

Alaylı G, Aydın F, Yılmaz Çoban A, et al. T helper 1 type cytokines polymorphisms: association with susceptibility to Behçet’s disease. Clin Rheumatol 2007;26(8):1299-305.11. Akman-Demir G, Tüzün E, Içöz S, et al. Interleukin-6 in neuro-Behçet's disease: association with disease subsets and long-term outcome. Cytokine 2008;44(3):373-6.

Shim J, Byun HO, Lee YD, et al. Interleukin-6 small interfering RNA improved the herpes simplex virusinduced systemic inflammation in vivo Behcet's diseaselike mouse model. Gene Ther 2009;16(3):415-25.

Chang HK, Jang WC, Park SB, et al. Association between interleukin 6 gene polymorphisms and Behçet’s disease in Korean people. Ann Rheum Dis 2005;64(2):339-40.

Storz K, Löffler J, Koch S, et al. IL-6 receptor, IL-8 receptor and TNF-alpha238 (G/A) polymorphisms are not associated with Behçet's disease in patients of German or Turkish origin. Clin Exp Rheumatol 2008;26(4 Suppl 50):S103-6.

Criteria for diagnosis of Behçet disease. International Study Group for Behçet Disease. Lancet 1990;335(8697):1078-80.

Bhakta BB, Brennan P, James TE, et al. Behçet’s disease: Evaluation of a new instrument to measure clinical activity. Rhumatology 1999;38:728-33.

Adam B, Calikoglu E. Serum interleukin-6, procalcitonin and C-reactive protein levels in subjects with active Behçet’s disease. J Eur Acad Dermatol Venereol2004;18(3):318-20.

Evereklioglu C, Er H, Türkz Y, et al. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet’s disease. Mediators Inflamm 2002;11(2):87-93.

Bazrafshani MR, Hajeer AH, Ollier WER, et al. IL-1B and IL-6 gene polymorphisms encode significant risk for the development of recurrent aphthous stomatitis (RAS). Genes Immu 2002;3(5):302-5.

How to Cite
1.
Hamzaoui A, Klii R, Harzallah O, Mahjoub T, Mahjoub S. Polymorphism of Interleukin 6 -174 G/C in Behcet Disease: Case Series and Review of Literature. Acta Med Iran. 52(11):811-815.
QRcode
Section
Articles